Pharmaceutical Executive Daily: Rethinking Workforce Development
In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the executive level.
The industry is seeing a growing investment in rare disease therapies and emerging opportunities and challenges in psychiatric drug development.
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.
New Leadership Analysis
A new leadership analysis emphasizes that building an effective biopharma workforce now requires going beyond traditional skill-building.
For C-suite leaders, the focus is shifting toward cultivating purpose-driven, agile cultures that attract and retain top talent.
Executives must balance digital transformation with employee well-being, embedding flexibility, inclusion, and cross-functional collaboration into workforce strategies.
Author's summary: Pharma leaders rethink workforce development.